Nicholas Donoghoe is VP at AbbVie Inc. (ABBV). They have made 5 open-market trades across 1 company since 2019, most recently 2026-08-14.
CIK 0001762951
1 open-market purchase totalling $996K since 2019, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ABBV | 74,430 | $21.9M |
Shares reported on the most recent Form 4, priced at the 2026-08-18 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ABBV | SELL | 2026-08-14 | 2026-08-18 | $250.00 | $8.2M | -2.8% | +0.4% | — |
| ABBV | SELL | 2025-08-05 | 2025-08-07 | $198.51 | $5.3M | +3.6% | +5.4% | +8.9% |
| ABBV | SELL | 2024-03-20 | 2024-03-22 | $176.30 | $7.4M | -6.2% | -6.2% | -3.8% |
| ABBV | SELL | 2023-12-26 | 2023-12-28 | $154.72 | $901K | +6.7% | +6.1% | +16.7% |
| ABBV | BUY | 2019-08-29 | 2019-08-30 | $66.19 | $996K | +7.7% | +15.1% | +33.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.